Data from one of three studies commissioned by the Juvenile Diabetes Research Foundation revealed reducing end-stage renal disease by 50% may help Medicare save up to $475 million for type 1 diabetes and $14 billion for type 2 diabetes after 10 years. In another study, researchers found new glucose-lowering methods may lead to Medicare savings of up to $810 million for type 1 and $45 billion for type 2 diabetes in 10 years. Reducing the severity of type 1 and type 2 diabetes by just 10% and 5%, respectively, could also help save billions in medical costs, researchers said in the third study.